Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × ribociclib × Breast × Clear all

Status

Recruiting 38 Completed 25 Active not recruiting 17 Terminated 8 Not yet recruiting 4 Unknown 3 Withdrawn 2 Enrolling by invitation 1 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

ribociclib 1 gedatolisib 1 Proton Pump Inhibitors 1 Hydrocortisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05038631 2025-12-02

Managed Access Programs for LEE011, Ribociclib

Novartis

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡